ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2022

CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis.

Fernando Alarid-Escudero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.